2025
SJR Q2
JCR Q3 · 2,4
76 eşleşen makale
SCIE
Dergi ayrıntısı
Prostaglandins Leukotrienes and Essential Fatty Acids
- Yayıncı
- Churchill Livingstone
- Ülke
- United Kingdom · Western Europe
- Tür
- journal
- ISSN
-
0952327815322823
Bütünleşik değerlendirme
Scopus tarafı Scimago SJR; WoS tarafı Master Journal List + JCR/JIF. Kaynaklar ISSN üzerinden eşleştirilir. WoS / JCR metrikleri yalnızca 1997 ve sonrası yıllar için vardır.
WoS / JCR verileri 1997 ve sonrası içindir.
Scopus
Scopus · Scimago
- SJR 0,832
- Quartile Q2
- H-Index 125
- Atıf/yayın 2,49
- Doküman (3y) 133
- Atıf (3y) 400
Clarivate
Web of Science · JCR · 2025
- JCR Q Q3
- JIF 2,4
- 5Y JIF 2,8
- JCI 0,54
WoS indeksleri
- SCIE
Konu sınıflandırması
Kategoriler (SJR)
Yıllık quartile karşılaştırması
Scimago (SJR) tüm yıllar; Clarivate (JCR / JIF / JCI) 1997 ve sonrası. Güncel yıl açık; diğer yıllar kapalıdır.
WoS / JCR verileri 1997 ve sonrası içindir.
| Yıl | SJR Q | JCR Q (1997+) | SJR | JIF (1997+) | 5Y JIF (1997+) | JCI (1997+) | JCI Q (1997+) | H-Index |
|---|---|---|---|---|---|---|---|---|
| 2025 | Q2 | Q3 | 0,832 | 2,4 | 2,8 | 0,54 | Q3 | 125 |
| 2024 | Q2 | Q2 | 0,856 | 3,2 | 2,9 | 0,59 | Q3 | 122 |
| 2023 | Q2 | Q3 | 0,805 | 2,9 | 3,2 | 0,6 | Q3 | 122 |
| 2022 | Q2 | Q3 | 0,679 | 3 | 3,3 | 0,55 | Q3 | 122 |
| 2021 | Q2 | Q3 | 0,885 | 3 | 3,6 | 0,64 | Q3 | 122 |
| 2020 | Q2 | Q2 | 1,059 | 4 | 3,7 | 0,72 | Q2 | 122 |
| 2019 | Q1 | Q3 | 0,925 | 2,9 | 2,7 | 0,7 | Q2 | 122 |
| 2018 | — | Q3 | — | 2,9 | 3,1 | 0,63 | Q3 | — |
| 2017 | Q1 | Q3 | 1,131 | 2,4 | 2,7 | 0,61 | Q3 | 122 |
| 2016 | Q1 | Q3 | 1,412 | 2,7 | 3 | — | — | 122 |
| 2015 | Q1 | Q2 | 1,248 | 3,2 | 2,9 | — | — | 122 |
| 2014 | Q2 | Q3 | 1,114 | 2,3 | 2,9 | — | — | 122 |
| 2013 | Q2 | Q3 | 1,072 | 2 | 2,7 | — | — | 122 |
| 2012 | Q2 | Q2 | 1,187 | 2,7 | 2,9 | — | — | 122 |
| 2011 | Q1 | Q2 | 1,358 | 3,4 | 3,2 | — | — | 122 |
| 2010 | Q2 | Q3 | 1,073 | 1,7 | 2,1 | — | — | 122 |
| 2009 | — | Q3 | — | 2,5 | 2,4 | — | — | — |
| 2008 | — | Q4 | — | 1,4 | 2,1 | — | — | — |
| 2007 | — | Q3 | — | 2 | 2,1 | — | — | — |
| 2006 | — | Q3 | — | 2,3 | — | — | — | — |
| 2005 | — | Q3 | — | 1,8 | — | — | — | — |
| 2004 | — | Q3 | — | 1,7 | — | — | — | — |
| 2003 | — | Q3 | — | 1,4 | — | — | — | — |
| 2002 | — | Q4 | — | 1 | — | — | — | — |
| 2001 | — | Q3 | — | 1,3 | — | — | — | — |
| 2000 | — | Q3 | — | 1,2 | — | — | — | — |
| 1999 | — | Q3 | — | 1,1 | — | — | — | — |
| 1998 | — | Q3 | — | 1,2 | — | — | — | — |
| 1997 | — | Q3 | — | 1,2 | — | — | — | — |
JCR kategori quartile geçmişi
Yıla ve kategoriye göre JCR / JCI quartile. 1997 ve sonrası.
WoS / JCR verileri 1997 ve sonrası içindir.
| Yıl | Kategori | Edition | JCR Q (1997+) | JCI Q (1997+) | Sıra |
|---|---|---|---|---|---|
| 2025 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q3 | Q3 | 244/328 |
| 2025 | CELL BIOLOGY | SCIE | Q4 | Q3 | 161/207 |
| 2025 | ENDOCRINOLOGY & METABOLISM | SCIE | Q3 | Q3 | 135/198 |
| 2024 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q2 | Q3 | 151/320 |
| 2024 | CELL BIOLOGY | SCIE | Q3 | Q3 | 111/204 |
| 2024 | ENDOCRINOLOGY & METABOLISM | SCIE | Q2 | Q3 | 86/193 |
| 2023 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q3 | Q3 | 178/313 |
| 2023 | CELL BIOLOGY | SCIE | Q3 | Q3 | 132/205 |
| 2023 | ENDOCRINOLOGY & METABOLISM | SCIE | Q3 | Q3 | 94/186 |
| 2022 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q3 | Q3 | 181/285 |
| 2022 | CELL BIOLOGY | SCIE | Q3 | Q3 | 133/191 |
| 2022 | ENDOCRINOLOGY & METABOLISM | SCIE | Q3 | Q3 | 99/145 |
| 2021 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q3 | Q3 | 211/297 |
| 2021 | CELL BIOLOGY | SCIE | Q4 | Q3 | 153/195 |
| 2021 | ENDOCRINOLOGY & METABOLISM | SCIE | Q3 | Q3 | 107/146 |
| 2020 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q2 | Q2 | 138/295 |
| 2020 | CELL BIOLOGY | SCIE | Q3 | Q2 | 118/195 |
| 2020 | ENDOCRINOLOGY & METABOLISM | SCIE | Q3 | Q2 | 74/146 |
| 2019 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q3 | Q2 | 165/297 |
| 2019 | CELL BIOLOGY | SCIE | Q3 | Q2 | 127/195 |
| 2019 | ENDOCRINOLOGY & METABOLISM | SCIE | Q3 | Q2 | 84/143 |
| 2018 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q3 | Q3 | 151/299 |
| 2018 | CELL BIOLOGY | SCIE | Q3 | Q3 | 124/193 |
| 2018 | ENDOCRINOLOGY & METABOLISM | SCIE | Q3 | Q3 | 83/145 |
| 2017 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q3 | Q3 | 180/293 |
| 2017 | CELL BIOLOGY | SCIE | Q3 | Q3 | 131/190 |
| 2017 | ENDOCRINOLOGY & METABOLISM | SCIE | Q3 | Q3 | 96/142 |
| 2016 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q3 | — | 152/290 |
| 2016 | CELL BIOLOGY | SCIE | Q3 | — | 118/190 |
| 2016 | ENDOCRINOLOGY & METABOLISM | SCIE | Q3 | — | 78/138 |
| 2015 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q2 | — | 115/289 |
| 2015 | CELL BIOLOGY | SCIE | Q3 | — | 95/187 |
| 2015 | ENDOCRINOLOGY & METABOLISM | SCIE | Q2 | — | 55/133 |
| 2014 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q3 | — | 173/290 |
| 2014 | CELL BIOLOGY | SCIE | Q3 | — | 130/184 |
| 2014 | ENDOCRINOLOGY & METABOLISM | SCIE | Q3 | — | 78/128 |
| 2013 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q3 | — | 210/291 |
| 2013 | CELL BIOLOGY | SCIE | Q4 | — | 141/185 |
| 2013 | ENDOCRINOLOGY & METABOLISM | SCIE | Q3 | — | 81/124 |
| 2012 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q3 | — | 152/290 |
| 2012 | CELL BIOLOGY | SCIE | Q3 | — | 111/185 |
| 2012 | ENDOCRINOLOGY & METABOLISM | SCIE | Q2 | — | 59/122 |
| 2011 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q2 | — | 110/290 |
| 2011 | CELL BIOLOGY | SCIE | Q2 | — | 88/181 |
| 2011 | ENDOCRINOLOGY & METABOLISM | SCIE | Q2 | — | 46/122 |
| 2010 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q3 | — | 208/286 |
| 2010 | CELL BIOLOGY | SCIE | Q4 | — | 146/178 |
| 2010 | ENDOCRINOLOGY & METABOLISM | SCIE | Q4 | — | 90/116 |
| 2009 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q3 | — | 149/283 |
| 2009 | CELL BIOLOGY | SCIE | Q3 | — | 99/162 |
| 2009 | ENDOCRINOLOGY & METABOLISM | SCIE | Q3 | — | 59/105 |
| 2008 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q4 | — | 215/275 |
| 2008 | CELL BIOLOGY | SCIE | Q4 | — | 138/157 |
| 2008 | ENDOCRINOLOGY & METABOLISM | SCIE | Q4 | — | 81/93 |
| 2007 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q3 | — | 168/263 |
| 2007 | CELL BIOLOGY | SCIE | Q3 | — | 107/156 |
| 2007 | ENDOCRINOLOGY & METABOLISM | SCIE | Q3 | — | 63/92 |
| 2006 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q3 | — | 147/262 |
| 2006 | CELL BIOLOGY | SCIE | Q3 | — | 94/156 |
| 2006 | ENDOCRINOLOGY & METABOLISM | SCIE | Q3 | — | 51/93 |
| 2005 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q3 | — | 172/261 |
| 2005 | CELL BIOLOGY | SCIE | Q3 | — | 105/153 |
| 2005 | ENDOCRINOLOGY & METABOLISM | SCIE | Q3 | — | 55/89 |
| 2004 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q3 | — | 167/261 |
| 2004 | CELL BIOLOGY | SCIE | Q3 | — | 107/155 |
| 2004 | ENDOCRINOLOGY & METABOLISM | SCIE | Q3 | — | 55/87 |
| 2003 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q3 | — | 191/261 |
| 2003 | CELL BIOLOGY | SCIE | Q3 | — | 114/156 |
| 2003 | ENDOCRINOLOGY & METABOLISM | SCIE | Q4 | — | 67/88 |
| 2002 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q4 | — | 209/266 |
| 2002 | CELL BIOLOGY | SCIE | Q4 | — | 124/153 |
| 2002 | ENDOCRINOLOGY & METABOLISM | SCIE | Q4 | — | 72/88 |
| 2001 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q3 | — | 203/308 |
| 2001 | CELL BIOLOGY | SCIE | Q3 | — | 103/147 |
| 2001 | ENDOCRINOLOGY & METABOLISM | SCIE | Q3 | — | 59/90 |
| 2000 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q3 | — | 207/310 |
| 2000 | CELL BIOLOGY | SCIE | Q3 | — | 103/147 |
| 2000 | ENDOCRINOLOGY & METABOLISM | SCIE | Q3 | — | 62/89 |
| 1999 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q3 | — | 202/295 |
| 1999 | CELL BIOLOGY | SCIE | Q4 | — | 106/141 |
| 1999 | ENDOCRINOLOGY & METABOLISM | SCIE | Q3 | — | 55/85 |
| 1998 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q3 | — | 182/295 |
| 1998 | CELL BIOLOGY | SCIE | Q3 | — | 96/139 |
| 1998 | ENDOCRINOLOGY & METABOLISM | SCIE | Q3 | — | 51/83 |
| 1997 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q3 | — | 167/253 |
| 1997 | CELL BIOLOGY | SCIE | Q3 | — | 86/130 |
| 1997 | ENDOCRINOLOGY & METABOLISM | SCIE | Q3 | — | 46/81 |